Randomized phase III trial of docetaxel versus vinorelbine or ifosfamide in patients with advanced non-small-cell lung cancer previously treated with platinum-containing chemotherapy regimens. The TAX 320 Non-Small Cell Lung Cancer Study Group. [electronic resource]
Producer: 20000718Description: 2354-62 p. digitalISSN:- 0732-183X
- Antineoplastic Agents, Phytogenic -- administration & dosage
- Carcinoma, Non-Small-Cell Lung -- drug therapy
- Disease Progression
- Disease-Free Survival
- Docetaxel
- Drug Resistance, Neoplasm
- Female
- Humans
- Ifosfamide -- administration & dosage
- Lung Neoplasms -- drug therapy
- Male
- Middle Aged
- Paclitaxel -- administration & dosage
- Survival Analysis
- Taxoids
- Treatment Outcome
- Vinblastine -- administration & dosage
- Vinorelbine
No physical items for this record
Publication Type: Clinical Trial; Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.